JP Morgan Chase’s Fusion Pharmaceuticals Inc. Common Shares FUSN Stock Holding History

JP Morgan Chase’s Portfolio FUSN Stock Details FUSN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-152,800	Closed	-$3.26M	–	7847
2024 Q1	$3.26M	Buy	+152,800	New	+$1.83M	﹤0.01%	3451

JP Morgan Chase's FUSN Position: Q2 2024 in Review

JP Morgan Chase sold out of Fusion Pharmaceuticals Inc. Common Shares (FUSN) in Q2 2024, closing a stake of 605,742 shares — an estimated $12.9M sold.

JP Morgan Chase first reported a position in FUSN in Q4 2020 and held it in 14 quarters. The position peaked at $12.9M in Q1 2024. 0 funds tracked by Wall St. Rank hold FUSN as of Q2 2024.

JP Morgan Chase reported no remaining Fusion Pharmaceuticals Inc. Common Shares position as of Q2 2024 after selling out during the quarter.
JP Morgan Chase sold 605,742 Fusion Pharmaceuticals Inc. Common Shares shares in Q2 2024, an estimated $12.9M.
JP Morgan Chase first reported a position in Fusion Pharmaceuticals Inc. Common Shares in Q4 2020 and held it in 14 quarters.
JP Morgan Chase's Fusion Pharmaceuticals Inc. Common Shares position peaked at $12.9M in Q1 2024.
0 funds tracked by Wall St. Rank held Fusion Pharmaceuticals Inc. Common Shares as of Q2 2024.

Based on JP Morgan Chase's 13F filing for Q2 2024, filed 12 Aug 2024.